CXCR4 and hepatocellular carcinoma: We further confirmed that the natural medicine, luteolin, inhibited the matrix stiffness-induced CXCR4-mediated YAP signaling pathway, proliferation, EMT, and stemness (Figure S9) thus identifying luteolin as a promising therapeutic agent for HCC.